Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

COVID-19 Instant Screening test, page-502

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 502 Last

Share
Profile

Follow
Myeverywish

3,464 Posts.

956

04/02/22

11:30

Post #: 59353721
Share

Originally posted by Red bar ↑

True that, it doesn't hold a lot of weight in my books as well but it is interesting how much of a premium Morningstar has chucked on top.. Also on top of that you have a lot of sell orders at much higher price points again doesn't hold a lot of weight as there could be a lot of silent sellers but it is of interest to me as well considering such a large chunk of the sell book is in the mid to high teens..

I think if the company can show a positive outcome from the two studies they ran overseas in India and the US in efficiency and specificity the share price could quickly re-rate to the upside. This is my point in mentioning the above and why I remain so bullish!

The company is currently crunching the data and if we show a positive outcome here we are showing this against something with already a very high accuracy. So let's say a larger prospective study is still required which may be the case the outcome of the data this time will not be flawed like it was last time in the US when we had three adjudicator's making the decisions who were incorrect 33% of the time due to relying on chest X-rays which have been proven to be not that accurate which skewered the results. We must remember this!!! If we have a positive outcome then this time the chances of success are more likely and not just for the COVID screening tool but for all of ResApps tec in general. Also if we do have to do a prospective trial I'm sure it will be over very quickly partnerships would be required like what we had when we used the three prestigious US hospital sites and they would most likely come to us if we have decent results... The study would likely to be done and dusted very quickly I mean look at all the case numbers out there in the real world at the moment it's mind-blowing! Remember this is all if we need to see results!!! Show us the goods if positive we are much more likely then to gain FDA clearance for Dx. Ironically I believe that SleepCheck will be the first product of ResApps technology to obtain FDA clearance thanks to Drozel, of similar accuracy to ResApp which already was approved sometime ago. We are due to receive word from the FDA regarding this application any day now... to be honest I don't really care much for the SleepCheck product as it's not what I initially invested my hard earned into this company for, it's a secondary product - my real excitement just with this is validation of our technology being proven by the FDA... I have had a good sit down and thought about of this logically yes the macro economic climate is currently pretty ordinary but if this play can start generating some serious near-term revenues and quickly turn-around (look at BRN machine learning is the future it is possible here... we have far less shares on issue then BRN) we just need something to ignite this, the COVID screening tool development could fire this up we just need high enough accuracy to show that it works...

Anyone know how many RAT tests have been sold globally and how much that is worth as a whole? .. What if RAP is far more accurate than RAT isn't it logical then to think the market will start to factor in forward-looking revenues and take into account how much the different RAT test globally are worth. I think wholesale the RAT test costs around $12 a pop so divide that by 10 whatever the sales are annually then apply that to RAP all just IMO!

Show us positive results RAP team and this will fly!!!

Cheers

Red bar

Expand

There are so many amazing things happening right now...

So many announcements on so many milestones expected...

While revenue is growing in the back ground ....from multiple revenue streams...

IMO. MB

RAP Price at posting: 7.1¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

Essential Energy conference: Streamlining approvals key to the green energy transition

EXR

Essential Energy conference: Elixir talks up unlocking QLD's Taroom Trough

88E

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

BPM

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

HVN

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

There are more pages in this discussion • 520 more messages in this thread...

First 502 Last

Add RAP (ASX) to my watchlist